Live Breaking News & Updates on Interest Group Pharma

Stay updated with breaking news from Interest group pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts for MSNBC All In With Chris Hayes 20240604 00:56:00

From texas, said cms is holding pharmaceutical companies hostage, jeopardizing future innovative treatments and the well-being of american patients. and the interest group pharma, which represents the pharmaceutical in industry, and spent something like $700 million lobbying on this, something like that, hundred million dollars. they say, what the white house isn t telling, you they re giving a single government agency power to arbitrarily set medicine prices were little accountability, oversight or input for patients and their doctors. with consequences long after the administration is gone. what do you say to the argument that this is going to stifle innovation in american drug research? well, during the inflation reduction act, deliberation in congress, the congressional budget office did a deep dive into this question. they really studied what the impact would be on innovation, and a future drug production. they found that it would limit the inflation reduction act would limit on ....

Interest Group Pharma , Well Being , 700 Million , 00 Million , White House , Medicine Prices , Government Agency , Isn T Telling , Inflation Reduction Act , Drug Research , Congressional Budget Office ,

Transcripts for MSNBC All In With Chris Hayes 20240604 07:56:00

Well-being of american patients. and the interest group pharma, which represents the pharmaceutical in industry, and spent something like $700 million lobbying on this, something like that, hundred million dollars. they say, what the white house isn t telling, you they re giving a single government agency power to arbitrarily set medicine prices were little accountability, oversight or input for patients and their doctors. with consequences long after the administration is gone. what do you say to the argument that this is going to stifle innovation in american drug research? well, during the inflation reduction act, deliberation in congress, the congressional budget office did a deep dive into this question. they really studied what the impact would be on innovation, and a future drug production. they found that it would limit the inflation reduction act would limit one drug, let me say that again, one drug over the next ten years. so, these arguments are really just palpably false. ....

Interest Group Pharma , White House , Well Being , Government Agency , Isn T Telling , 700 Million , 00 Million , Inflation Reduction Act , Medicine Prices , Drug Research , Congressional Budget Office ,